What is Alamar Biosciences 's stock issuance proceeds?

Alamar Biosciences (ALMR) reported stock issuance proceeds of $1.8M in Q1 2026.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Alamar Biosciences ALMR Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

HubSpotHUBS

$16.31M-15.5%

BJ's Wholesale Club Holdings, Inc.BJ

$125K-97.5%

Allegro MicroSystems, Inc.ALGM

$0—

EOG ResourcesEOG

$1M—

Dominion EnergyD

$33M-5.7%

TG TherapeuticsTGTX

$763K+3,533%

Other financials

Income statement

See full

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

See full

Cash & equivalents$64.6M—

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

See full

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

See full

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

See full

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alamar Biosciences 's stock issuance proceeds?: Alamar Biosciences (ALMR) reported stock issuance proceeds of $1.8M in Q1 2026.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.